NasdaqGM - Nasdaq Real Time Price USD

Actuate Therapeutics, Inc. Common stock (ACTU)

10.98
+0.38
+(3.58%)
At close: May 21 at 4:00:01 PM EDT
10.98
0.00
(0.00%)
After hours: May 21 at 4:04:13 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
Operating Expense
23,753.06
25,160.73
24,973.83
20,206.81
Operating Income
-23,753.06
-25,160.73
-24,973.83
-20,206.81
Net Non Operating Interest Income Expense
242.43
203.58
309.03
10.83
Other Income Expense
--
-2,328.17
-79.82
36.58
Pretax Income
-25,306.29
-27,285.33
-24,744.62
-20,159.40
Net Income Common Stockholders
-25,306.29
-27,285.33
-24,744.62
-20,159.40
Diluted NI Available to Com Stockholders
-25,306.29
-27,285.33
-24,744.62
-20,159.40
Basic EPS
-3.15
-3.26
-1.29
-1.34
Diluted EPS
-3.15
-3.26
-1.29
-1.34
Basic Average Shares
19,531.64
8,372.74
19,111.64
15,033.73
Diluted Average Shares
19,531.64
8,372.74
19,111.64
15,033.73
Total Operating Income as Reported
-23,753.06
-25,160.73
-24,973.83
-20,206.81
Total Expenses
23,753.06
25,160.73
24,973.83
20,206.81
Net Income from Continuing & Discontinued Operation
-25,306.29
-27,285.33
-24,744.62
-20,159.40
Normalized Income
-25,603.15
-27,549.67
-24,664.80
-20,195.98
Interest Income
261.13
222.29
352.67
27.03
Interest Expense
18.70
18.72
43.64
16.20
Net Interest Income
242.43
203.58
309.03
10.83
EBIT
-25,287.59
-27,266.61
-24,700.98
-20,143.20
EBITDA
-25,287.59
-27,266.61
-24,700.98
-20,143.20
Net Income from Continuing Operation Net Minority Interest
-25,306.29
-27,285.33
-24,744.62
-20,159.40
Total Unusual Items Excluding Goodwill
296.85
264.34
-79.82
36.58
Total Unusual Items
296.85
264.34
-79.82
36.58
Normalized EBITDA
-25,584.44
-27,530.95
-24,621.16
-20,179.78
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 8/13/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RNTX Rein Therapeutics Inc.
1.9400
+0.52%
 
COYA Coya Therapeutics, Inc.
5.67
-3.24%
 
CUE Cue Biopharma, Inc.
0.6012
-10.22%
 
INAB IN8bio, Inc.
0.1260
-3.08%
 
APTOF Aptose Biosciences Inc.
1.6800
-5.62%
 
RNXT RenovoRx, Inc.
1.2200
0.00%
 
GNTA Genenta Science S.p.A.
4.1400
-3.72%
 
APS.TO Aptose Biosciences Inc.
2.4000
+1.27%
 
LTRN Lantern Pharma Inc.
3.3400
-4.02%
 
DSGN Design Therapeutics, Inc.
3.6000
-1.91%